BIOMARKERS AND BOWEL URGENCY IN RESPONSE TO MIRIKIZUMAB FOR ULCERATIVE COLITIS

Marla C. Dubinsky  1     April Naegeli  2     Mingyang Shan  2     Sylvie Bradesi  2     Jochen Schmitz  2     Catherine Milch  2     Cem Kayhan  3     Simon Travis    
1 Mount Sinai Hospital, Mount Sinai,New York City,United States
2 Eli Lilly and Company,Indianapolis,United States
3 Eli Lilly and Company,

Session
IBD (Posters)

Citation
United European Gastroenterology Journal 2021; 9 (Supplement 1)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Forgot your password?

Reset myUEG password

Social Sharing